CompletedNot Applicable

Plasma Vitamin and Homocysteine Levels and Thrombosis in Patients With Ph-negative MPNs

Turkey (Türkiye)Started 2003-01

Plain-language summary

Hyperhomocysteinemia is a risk for thrombosis. Thrombosis is more frequent in myeloproliferative neoplasms (MPNs) than the normal population. In this study, we investigated the thrombosis incidence, the effects of plasma homocysteine levels on thrombosis, and the correlations between folate, cobalamin, pyridoxine and homocysteine levels in MPNs, and to compare these results with the healthy controls.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Adult MPN patients and healthy controls who gave a written consent were included in the study. Exclusion Criteria: Exclusion criteria included not giving a written consent and using medications without an indication which may have an effect on plasma homocysteine and vitamin levels.

What they're measuring

Thrombosis

Timeframe: at least 1 year

Trial details

NCT IDNCT01878916

SponsorIstanbul University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2004-06

View on ClinicalTrials.gov More Thrombosis trials